Neurology: Loss of Phosphodiesterase 4 in Parkinson Disease: Relevance to Cognitive Deficits is organized by American Academy of Neurology (AAN) and will be held during Aug 08, 2017 - Aug 08, 2020.
The target audience for this medical event is physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits.
Conference Objectives are :
Upon completion of the article by Niccolini et al, the participant should be able to:
• List regions in which decreased phosphodiesterase 4 (PDE4) expression was found in patients with Parkinson disease (PD) in this study
• Discuss which clinical features observed in this study were significantly associated with PDE4 expression
• Discuss the clinical significance of decreased PDE4 expression in patient with PD discussed in this study
Additional details will be posted as soon as they are available.
Neurology, Pediatrics, Molecular Biology